Skip to content

Clinical trials

Phase 1/2 Lymphoma, Mantle-Cell trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 1/2 Country / region: Belgium Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ADC Therapeutics S.A.1
BeOne Medicines1
Genmab1
Lakefront Biotherapeutics NV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell4
Lymphoma, Large B-Cell, Diffuse3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Follicular2
Burkitt Lymphoma1
Lymphoma1
Lymphoma, B-Cell1
Lymphoma, Non-Hodgkin1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.